Impact of Multidomain Frailty on the Mode of Death in Older Patients With Heart Failure: A Cohort Study
Koichi Ohashi,Yuya Matsue,Daichi Maeda,Yudai Fujimoto,Nobuyuki Kagiyama,Tsutomu Sunayama,Taishi Dotare,Kentaro Jujo,Kazuya Saito,Kentaro Kamiya,Hiroshi Saito,Yuki Ogasahara,Emi Maekawa,Masaaki Konishi,Takeshi Kitai,Kentaro Iwata,Hiroshi Wada,Masaru Hiki,Takatoshi Kasai,Hirofumi Nagamatsu,Tetsuya Ozawa,Katsuya Izawa,Shuhei Yamamoto,Naoki Aizawa,Kazuki Wakaume,Kazuhiro Oka,Shin-Ichi Momomura,Tohru Minamino,Koichi OhashiYuya MatsueDaichi MaedaYudai FujimotoNobuyuki KagiyamaTsutomu SunayamaTaishi DotareKentaro JujoKazuya SaitoKentaro KamiyaHiroshi SaitoYuki OgasaharaEmi MaekawaMasaaki KonishiTakeshi KitaiKentaro IwataHiroshi WadaMasaru HikiTakatoshi KasaiHirofumi NagamatsuTetsuya OzawaKatsuya IzawaShuhei YamamotoNaoki AizawaKazuki WakaumeKazuhiro OkaShin-ichi MomomuraTohru MinaminoDepartment of Cardiovascular Biology and Medicine,Juntendo University Graduate School of Medicine,Tokyo,Japan. (K.O.,Y.M.,D.M.,Y.F.,N.K.,T.S.,T.D.,M.H.,T.K.,T.M.)Cardiovascular Respiratory Sleep Medicine,Juntendo University Graduate School of Medicine,Tokyo,Japan. (T.K.)Department of Digital Health and Telemedicine R&D,Juntendo University Graduate School of Medicine,Tokyo,Japan. (N.K.)Department of Cardiology,Tokyo Metropolitan Bokutoh Hospital,Japan (K.O.).Department of Cardiology,The Sakakibara Heart Institute of Okayama,Japan. (N.K.)Department of Rehabilitation,The Sakakibara Heart Institute of Okayama,Japan. (K.S.)Department of Nursing,The Sakakibara Heart Institute of Okayama,Japan. (Y.O.)Department of Cardiology,Nishiarai Heart Centre Hospital,Tokyo,Japan (K.J.).Department of Rehabilitation,School of Allied Health Sciences,Kitasato University,Sagamihara,Japan. (K.K.)Department of Cardiovascular Medicine,Kitasato University,Sagamihara,Japan. (E.M.)Department of Rehabilitation,Kameda Medical Centre,Kamogawa,Japan (H.S.).Division of Cardiology,Yokohama City University Medical Centre,Japan (M.K.).Department of Cardiovascular Medicine,National Cerebral and Cardiovascular Centre,Osaka,Japan (T.K.).Department of Rehabilitation,Kobe City Medical Centre General Hospital,Japan (K.I.).Department of Cardiovascular Medicine,Saitama Medical Centre,Jichi Medical University,Japan (H.W.).Department of Cardiology,Tokai University School of Medicine,Isehara,Japan (H.N.).Department of Rehabilitation,Odawara Municipal Hospital,Japan (T.O.).Department of Rehabilitation,Matsui Heart Clinic,Japan (K.I.).Department of Rehabilitation,Shinshu University Hospital,Matsumoto,Japan (S.Y.).Department of Cardiovascular Medicine,Nephrology and Neurology,University of the Ryukyus,Okinawa,Japan (N.A.).Department of Rehabilitation,Kitasato University Medical Centre,Saitama,Japan (K.W.).Saitama Citizens Medical Centre,Japan (K.O.,S.M.).Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology,Japan Agency for Medical Research and Development,Tokyo,Japan (T.M.).
DOI: https://doi.org/10.1161/circoutcomes.123.010416
2024-03-28
Circulation Cardiovascular Quality and Outcomes
Abstract:Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Although frailty is strongly associated with mortality in patients with heart failure (HF), the risk of which specific cause of death is associated with being complicated with frailty is unclear. We aimed to clarify the association between multidomain frailty and the causes of death in elderly patients hospitalized with HF.METHODS:We analyzed data from the FRAGILE-HF cohort, where patients aged 65 years and older, hospitalized with HF, were prospectively registered between 2016 and 2018 in 15 Japanese hospitals before discharge and followed up for 2 years. All patients were assessed for physical, social, and cognitive dysfunction, and categorized into 3 groups based on their number of frailty domains (FDs, 0–1, 2, and 3). Kaplan-Meier survival analysis was used to evaluate the association between the number of FDs and all-cause mortality, whereas Fine-Gray competing risk regression analysis was used for assessing the impact on cause-specific mortality.RESULTS:We analyzed 1181 patients with HF (81 years old in median, 57.4% were male), 530 (44.9%), 437 (37.0%), and 214 (18.1%) of whom were categorized into the FD 0 to 1, FD 2, and FD 3 groups, respectively. During the 2-year follow-up, 240 deaths were observed (99 HF deaths, 34 cardiovascular deaths, and 107 noncardiovascular deaths), and an increase in the number of FD was significantly associated with mortality (Log-rank:P<0.001). The Fine-Gray competing risk analysis adjusted for age and sex showed that FDs 2 (subdistribution hazard ratio, 1.77 [95% CI, 1.11–2.81]) and 3 (2.78, [95% CI, 1.69–4.59]) groups were associated with higher incidence of noncardiovascular death but not with HF and other cardiovascular deaths.CONCLUSIONS:Although multidomain frailty is strongly associated with mortality in older patients with HF, it is mostly attributable to noncardiovascular death and not cardiovascular death, including HF death.REGISTRATION:URL:https://www.clinicaltrials.gov; Unique identifier: UMIN000023929
cardiac & cardiovascular systems